The combination of Merck's Welireg and Eisai's Lenvima has not yet shown statistical significance in extending overall ...

After a progression-free survival win last year raised hopes for the combo's potential in hepatocellular carcinoma, an overall survival miss brings the study to a close.

Rare disease drug development presents unique challenges: patient populations are often minimal, clinical endpoints may not ...

EDP-323 significantly reduced mean viral load AUC by 85% and 87% in the high- and low-dose groups, respectively, compared ...

The LITESPARK-022 and LITESPARK-011 trials evaluated combination regimens containing belzutifan in patients with advanced clear cell RCC.

As the most immediate and active touchpoint for sensitive data, the endpoint plays a pivotal role in the data security ...

A wrist-worn, AI-driven transcutaneous peripheral nerve stimulator is linked to greater improvement in patients with ...

Moderna said its cytomegalovirus (CMV) vaccine didn't meet the primary efficacy endpoint in a Phase 3 trial, and it is discontinuing the clinical development program.

Endpoint security firm Igel has partnered with Palo Alto Networks on a secure access service edge (SASE) solution.

The US Cybersecurity and Infrastructure Security Agency (CISA) has added a critical severity Motex Landscope Endpoint Manager ...

The U.S. Cybersecurity and Infrastructure Security Agency (CISA) on Wednesday added a critical security flaw impacting Motex ...